Home > Adults > Dermatology >

Rosacea

Checked: 23-08-2020 by Vicky Ryan Next Review: 23-08-2021

Principles of Management

Local Clinicians recommend following Guidelines as below:

Primary Care Dermatology Society: Rosacea clinical guidance

National Institute for Health and Social Care (NICE): Stepped approach to managing Rosacea and differential diagnosis list included for information here. cks.nice.org.uk/rosacea-acne

Always refer to the BNSSG Adult Joint Formulary for prescribing Guidelines: remedy.bnssgccg.nhs.uk/formulary-adult/chapters/13-skin/137-rosacea-and-acne/

Rhinopyhma – More common in men. Commonly associated with untreated rosacea but can be present without other signs.

Rare variant of rosacea – Granulomatous Rosacea.

Consider differential diagnosis of Systemic lupus erythematosus (SLE) with photosensitive rash in butterfly distribution, particularly in young women.

Red Flags

Ocular involvement is an indication for systemic rather than topical treatment and if Keratitis is suspected prompt referral to Ophthalmologist is advised.

Resources

British Association of Dermatology:

Patient information leaflet (Rosacea): bad.org.uk/patient-information-leaflets/rosacea

Patient information leaflet (Rhinopyhma): https://www.bad.org.uk/pils/rhinophyma

Changing Faces:

Advice and support and information on skin camouflage:changingfaces.org.uk/

British Skin Foundation: Helpline and advice: britishskinfoundation.org.uk/

Dermatology Life Quality index (DLQI): cardiff.ac.uk/medicine/resources/quality-of-life-questionnaires/dermatology-life-quality-index

Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.